Cancerous Breast Articles & Analysis
18 news found
LOS ANGELES, CA – October 6, 2022 – T-Cure Bioscience, Inc., a privately held company focused on developing T cell receptor (TCR) therapy products for the treatment of solid tumors, today announced that the National Cancer Institute (NCI) and Rutgers University sites are open to recruit patients for the treatment of Kita-Kyushu lung cancer antigen 1 ...
C2i Genomics, a cancer intelligence company, today announced expansion into Europe through a strategic partnership with OncoDNA, a genomic and theranostic company specializing in precision medicine for the treatment of patients with cancer and genetic diseases. ...
Eligible tumor types include advanced non-small cell lung cancer, colorectal cancer, head and neck cancer, gastric cancer, breast cancer, ovarian cancer, and pancreatic cancer. ...
Breast cancer surpassed lung cancer in 2020 as the most frequently diagnosed cancer in the world with 2.3 million newly diagnosed cases and more than 650,000 deaths annually. The two organizations share a common mission to develop sustainable and replicable comprehensive cancer centers of excellence to offer ...
As early as around 1800, doctors discovered that certain cancer patients would have their symptoms reduced after being briefly infected with viruses. ...
Sherman Oaks, CA – March 17, 2021 – T-Cure Bioscience, Inc., a privately held company focused on developing T cell receptor (TCR) therapy products for the treatment of solid tumors, today announced that the Company has entered into a clinical research agreement with Rutgers, The State University of New Jersey, to fund a Phase I clinical study testing a TCR-based product candidate for ...
A growing number of HERV genes and proteins are expressed in different cancers raising the possibility that HERV derived antigens might represent excellent targets for tumor immunotherapy. ...
IMPACT Lourdes members voted to award $30,000 to purchase the MarginProbe system, equipment that assists in detecting cancerous breast tissue. With MarginProbe, surgeons can assess breast tissue in the operating room to give them greater confidence that they successfully removed all the cancer in the first lumpectomy surgery. ...
ORYX, a translational medicine company focused on oncolytic virotherapy and cancer vaccines, today reported new results on the mode of action of oncolytic virus ParvOryx in human ovarian cancer explants. ...
ORYX, a translational medicine company focused on oncolytic virotherapy and cancer vaccines, today provided an update on the development strategy for oncolytic virus ParvOryx, a wild type rat oncolytic parvovirus (H-1PV). ...
ORYX, a translational medicine company focused on oncolytic virotherapy and cancer vaccines, today published positive clinical trial results from a dose-escalating Phase I/IIa trial with oncolytic virus ParvOryx in metastatic, inoperable pancreatic cancer. ...
“The discussion was both timely and enlightening, and it is clear that some of the leading players in the space are finally beginning to refocus resources on early cancer detection as perhaps the only viable long-term and cost-effective solution to curable approaches in ...
Cleveland Diagnostics, Inc., a clinical-stage company focused on developing next-generation diagnostic tests for the detection of cancers, today announced the online publication of results from a multicenter validation study of IsoPSA™, a novel structure-based prostate cancer assay, in Journal of Urology. ...
“We had realized at the institute that trying to understand autism without understanding the subtypes would be like trying to understand cancer without specifically going after lung cancer, breast cancer, or other cancers, because there might be different causes and treatments,” he says. ...
Raising Awareness Seno Medical initiated a building-wide Breast Cancer Awareness Day at the Callaghan Tower in the medical center district of San Antonio. ...
In fact, a lack of vitamin D has been asscoiated with conditions such as prostate cancer, breast cancer, heart disease and, perhaps unsurprisingly, depression. ...
Cleveland Diagnostics, Inc., a biotechnology company focused on developing next-generation diagnostics for the detection of cancers, today announced the online publication of interim results for an ongoing multi-center trial of the IsoPSA™ prostate cancer test in European Urology. ...
For example, cancerous breast cells can spread to a lung and form a new breast cancer tumor there. ...